These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 32712535)
1. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors. Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535 [TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and evaluation of pyrazole derivatives as non-nucleoside hepatitis B virus inhibitors. Jia H; Bai F; Liu N; Liang X; Zhan P; Ma C; Jiang X; Liu X Eur J Med Chem; 2016 Nov; 123():202-210. PubMed ID: 27484509 [TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors. Ma Y; Zhao S; Ren Y; Cherukupalli S; Li Q; Woodson ME; Bradley DP; Tavis JE; Liu X; Zhan P Eur J Med Chem; 2021 Dec; 225():113780. PubMed ID: 34438123 [TBL] [Abstract][Full Text] [Related]
4. Identification of (6S)-cyclopropyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxamines as new HBV capsid assembly modulators. Lv K; Wu S; Tao Z; Wang A; Xu S; Yang L; Gao Q; Wang A; Qin X; Jiang B; Wu W; Jia X; Li Y; Jiang J; Liu M Eur J Med Chem; 2022 Jan; 228():113974. PubMed ID: 34772528 [TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and primary biological evaluation of the novel 2-pyridone derivatives as potent non-nucleoside HBV inhibitors. Jia H; Song Y; Yu J; Zhan P; Rai D; Liang X; Ma C; Liu X Eur J Med Chem; 2017 Aug; 136():144-153. PubMed ID: 28494252 [TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and evaluation of novel heteroaryldihydropyrimidine derivatives as non-nucleoside hepatitis B virus inhibitors by exploring the solvent-exposed region. Yu J; Jia H; Guo X; Desta S; Zhang S; Zhang J; Ding X; Liang X; Liu X; Zhan P Chem Biol Drug Des; 2020 Jun; 95(6):567-583. PubMed ID: 30825248 [TBL] [Abstract][Full Text] [Related]
7. A new series of HAPs as anti-HBV agents targeting at capsid assembly. Yang XY; Xu XQ; Guan H; Wang LL; Wu Q; Zhao GM; Li S Bioorg Med Chem Lett; 2014 Sep; 24(17):4247-9. PubMed ID: 25127104 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel dihydrobenzodioxine derivatives as HBV capsid protein inhibitors. Liu L; Wang M; Li C; Han X; Xie Y; Feng K; Zhang L; Chen Y; Jia H Bioorg Chem; 2022 Nov; 128():106052. PubMed ID: 35921789 [TBL] [Abstract][Full Text] [Related]
9. Identification of a new class of HBV capsid assembly modulator. Kuduk SD; Stoops B; Alexander R; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD Bioorg Med Chem Lett; 2021 May; 39():127848. PubMed ID: 33610748 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation and molecular docking studies of phenylpropanoid derivatives as potent anti-hepatitis B virus agents. Liu S; Wei W; Li Y; Liu X; Cao X; Lei K; Zhou M Eur J Med Chem; 2015 May; 95():473-82. PubMed ID: 25847765 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and anti-HBV activity study of novel HBV capsid assembly modulators. Liang M; Liu L; Liu J; Yang Z; Wang M; Xie Y; Cai Y; Xue P; Chen Y; Zhan P; Jia H Bioorg Med Chem Lett; 2024 Nov; 112():129913. PubMed ID: 39111727 [TBL] [Abstract][Full Text] [Related]
12. Study on 2-arylthio-5-iodo pyrimidine derivatives as novel nonnucleoside inhibitors against hepatitis B virus DNA replication. Zhao J; Tu J; Fan N; Chen X; Lu F; Zhang Y; Zhang L; Tian C; Zhang Z; Liu J; Wang X Future Med Chem; 2016 May; 8(7):751-63. PubMed ID: 27172826 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors. Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors. Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiviral evaluation of novel heteroarylpyrimidines analogs as HBV capsid effectors. Boucle S; Lu X; Bassit L; Ozturk T; Russell OO; Amblard F; Coats SJ; Schinazi RF Bioorg Med Chem Lett; 2017 Feb; 27(4):904-910. PubMed ID: 28094179 [TBL] [Abstract][Full Text] [Related]
16. Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4). Ren Q; Liu X; Luo Z; Li J; Wang C; Goldmann S; Zhang J; Zhang Y Bioorg Med Chem; 2017 Feb; 25(3):1042-1056. PubMed ID: 28082068 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays. Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800 [TBL] [Abstract][Full Text] [Related]
18. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly. Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. Liu S; Li Y; Wei W; Wang K; Wang L; Wang J Chem Biol Interact; 2016 May; 251():1-9. PubMed ID: 26980103 [TBL] [Abstract][Full Text] [Related]
20. 2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors. Wang J; Zhang L; Zhao J; Zhang Y; Liu Q; Tian C; Zhang Z; Liu J; Wang X Bioorg Med Chem; 2018 May; 26(8):1573-1578. PubMed ID: 29459146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]